A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5377 (2006.01) A61K 31/197 (2006.01) A61K 31/506 (2006.01) A61P 9/08 (2006.01)
Patent
CA 2615051
The invention relates to the use of compounds of formulae (I-VI) for the production of a medicament for the treatment of primary and secondary Raynaud's phenomenon.
L'invention concerne l'utilisation de composés de formules (I-VI) pour produire un médicament destiné au traitement du phénomène de Raynaud primaire et secondaire.
Krahn Thomas
Stasch Johannes-Peter
Thielemann Wolfgang
Weimann Gerrit
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Use of soluble guanylate cyclase for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of soluble guanylate cyclase for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of soluble guanylate cyclase for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1574468